IDH2 and neoplasm: In multivariable analysis, IDH2 and TP53 mutations were independent predictors of worse survival.<h4>Conclusion</h4>IDH2 and TP53 mutations are enriched in dedifferentiated CS and are significant, independent predictors of adverse survival, regardless of tumor grade.